These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 38725203

  • 1. Response to Lisinopril in Patients with Sickle Cell Anemia and Proteinuria.
    Aleem A, Al-Sultan A, Alsuwaida A, Alsaleh K, Algahtani F, Almomen A, Sharif M, Alotaibi GS.
    Saudi J Kidney Dis Transpl; 2023 Nov 01; 34(6):531-536. PubMed ID: 38725203
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Angiotensin-converting enzyme (ACE) inhibitors for proteinuria and microalbuminuria in people with sickle cell disease.
    Sasongko TH, Nagalla S, Ballas SK.
    Cochrane Database Syst Rev; 2013 Mar 28; (3):CD009191. PubMed ID: 23543572
    [Abstract] [Full Text] [Related]

  • 4. Angiotensin-converting enzyme (ACE) inhibitors for proteinuria and microalbuminuria in people with sickle cell disease.
    Sasongko TH, Nagalla S, Ballas SK.
    Cochrane Database Syst Rev; 2015 Jun 04; 2015(6):CD009191. PubMed ID: 26041152
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Renal tubular peptide catabolism in chronic vascular rejection.
    Rustom R, Grime JS, Sells RA, Amara A, Jackson MJ, Shenkin A, Maltby P, Smith L, Hammad A, Brown M, Bone JM.
    Ren Fail; 2001 Jun 04; 23(3-4):517-31. PubMed ID: 11499566
    [Abstract] [Full Text] [Related]

  • 11. Therapeutic resistance to angiotensin converting enzyme (ACE) inhibition is related to pharmacodynamic and -kinetic factors in 5/6 nephrectomized rats.
    Windt WA, van Dokkum RP, Kluppel CA, Jeronimus-Stratingh CM, Hut F, de Zeeuw D, Henning RH.
    Eur J Pharmacol; 2008 Feb 02; 580(1-2):231-40. PubMed ID: 18036585
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Proximal renal tubular peptide catabolism, ammonia excretion and tubular injury in patients with proteinuria: before and after lisinopril.
    Rustom R, Grime JS, Costigan M, Maltby P, Hughes A, Shenkin A, Critchley M, Bone JM.
    Clin Sci (Lond); 1998 Apr 02; 94(4):425-30. PubMed ID: 9640348
    [Abstract] [Full Text] [Related]

  • 17. Dual renin-angiotensin system blockade at optimal doses for proteinuria.
    Laverman GD, Navis G, Henning RH, de Jong PE, de Zeeuw D.
    Kidney Int; 2002 Sep 02; 62(3):1020-5. PubMed ID: 12164886
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Antiproteinuric effect predicts renal protection by angiotensin-converting enzyme inhibition in rats with established adriamycin nephrosis.
    Wapstra FH, Van Goor H, Navis G, De Jong PE, De Zeeuw D.
    Clin Sci (Lond); 1996 May 02; 90(5):393-401. PubMed ID: 8665777
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.